Iovance Biotherapeutics Optimizes Headquarters for Cost Efficiency

TipRanksNov 21 17:49 ET

High Quality 'SMID-cap' Stocks With Cyclical Exposure – MS

Seeking AlphaNov 19 11:47 ET

Iovance Biotherapeutics Call Volume Above Normal and Directionally Bullish

TipRanksNov 15 13:30 ET

JMP Securities Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsNov 11 00:31 ET · Ratings

Iovance Biotherapeutics: Promising Growth and Expansion in Cancer Treatment Fuels Buy Rating

TipRanksNov 11 00:26 ET

A Quick Look at Today's Ratings for Iovance Biotherapeutics(IOVA.US), With a Forecast Between $21 to $32

Moomoo NewsNov 9 08:00 ET · Ratings